Compare PEPG & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEPG | SUNS |
|---|---|---|
| Founded | 2018 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.7M | 109.2M |
| IPO Year | 2022 | N/A |
| Metric | PEPG | SUNS |
|---|---|---|
| Price | $1.47 | $8.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $11.17 | $8.75 |
| AVG Volume (30 Days) | ★ 801.1K | 77.2K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 16.17% |
| EPS Growth | ★ 25.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $70.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.84 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $7.34 |
| 52 Week High | $7.80 | $11.78 |
| Indicator | PEPG | SUNS |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 72.80 |
| Support Level | $1.32 | $7.39 |
| Resistance Level | $5.37 | $9.69 |
| Average True Range (ATR) | 0.12 | 0.25 |
| MACD | 0.05 | 0.13 |
| Stochastic Oscillator | 21.11 | 96.52 |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.